Top

Published in:

01-10-2017 | Letter to the Editors

Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France

Authors: Damien Biotti, Fabrice Bonneville, Emilie Tournaire, Xavier Ayrignac, Clarisse Carra Dallière, Laurence Mahieu, Catherine Vignal, Cecile Dulau, Bruno Brochet, Aurélie Ruet, Jean-Christophe Ouallet, Olivier Gout, Françoise Heran, Nicolas Menjot de Champfleur, Thomas Tourdias, Marc Deneve, Pierre Labauge, Romain Deschamps

Published in: Journal of Neurology | Issue 10/2017

Excerpt

Dear Sirs, …

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation 13(1):279. doi:10.1186/s12974-016-0717-1 CrossRefPubMedPubMedCentral

Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184. doi:10.1186/1742-2094-8-184 CrossRefPubMedPubMedCentral

Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70(23):2197–2200. doi:10.1212/01.wnl.0000303817.82134.da CrossRefPubMed

Akaishi T, Nakashima I, Takeshita T, Mugikura S, Sato DK, Takahashi T, Nishiyama S, Kurosawa K, Misu T, Nakazawa T, Aoki M, Fujihara K (2016) Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. J Neuroimmunol 293:28–33. doi:10.1016/j.jneuroim.2016.02.004 CrossRefPubMed

Martinez-Hernandez E, Sepulveda M, Rostasy K, Hoftberger R, Graus F, Harvey RJ, Saiz A, Dalmau J (2015) Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor alpha1 Subunit in patients with isolated optic neuritis. JAMA Neurol 72(2):187–193. doi:10.1001/jamaneurol.2014.3602 CrossRefPubMedPubMedCentral

Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, Kurosawa K, Kaneko K, Kuroda H, Nishiyama S, Misu T, Nakazawa T, Fujihara K, Aoki M (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87(4):446–448. doi:10.1136/jnnp-2014-310206 CrossRefPubMed

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13(1):280. doi:10.1186/s12974-016-0718-0 CrossRefPubMedPubMedCentral

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation 13(1):282. doi:10.1186/s12974-016-0720-6 CrossRefPubMedPubMedCentral

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189. doi:10.1212/WNL.0000000000001729 CrossRefPubMedPubMedCentral

Title: Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France
Authors: Damien Biotti
Fabrice Bonneville
Emilie Tournaire
Xavier Ayrignac
Clarisse Carra Dallière
Laurence Mahieu
Catherine Vignal
Cecile Dulau
Bruno Brochet
Aurélie Ruet
Jean-Christophe Ouallet
Olivier Gout
Françoise Heran
Nicolas Menjot de Champfleur
Thomas Tourdias
Marc Deneve
Pierre Labauge
Romain Deschamps
Publication date: 01-10-2017
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 10/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-017-8615-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2017

Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment

Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy

Neurological complications of Behçet’s syndrome

A dedicated lumbar puncture clinic: performance and short-term patient outcomes

What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients